16Jun
Diligence Clauses and the Management of Uncertainty in Life Sciences Agreements
In times of uncertainty and disruption, setting expectations for performance with business partners and contractual counterparties can be more complicated than ever. Companies that develop drugs, biologics and medical devices have considerable...
By:
Skadden, Arps, Slate, Meagher & Flom LLP
Related
The Department of Treasury and the Internal Revenue Service (the “IRS”) have issued IRS Notice 202...
Read More >
On February 27, 2020, the Ninth Circuit issued a long-anticipated decision in Rizo v. Yovino. Consis...
Read More >
When the COVID-19 lockdown regulations unexpectedly disrupted ‘receipts’, whilst leaving ‘disburs...
Read More >
Amendment to Law Simplifies Terminations of Employment Contracts - New Legislation Enacted - On Ju...
Read More >
Welcome back to Sherlock Holmes week. It does look like I will got carried away and it will become 1...
Read More >
Among various other disruptions and turbulence that COVID-19 has brought to the construction industr...
Read More >